The demethylase inhibitor GSK-J4 limits inflammatory colitis by promoting de novo synthesis of retinoic acid in dendritic cells
Abstract Dendritic cells (DCs) promote T-cell mediated tolerance to self-antigens and induce inflammation to innocuous-antigens. This dual potential makes DCs fundamental players in inflammatory disorders. Evidence from inflammatory colitis mouse models and inflammatory bowel diseases (IBD) patients...
Guardado en:
Autores principales: | Cristian Doñas, Jocelyn Neira, Francisco Osorio-Barrios, Macarena Carrasco, Dominique Fernández, Carolina Prado, Alejandra Loyola, Rodrigo Pacheco, Mario Rosemblatt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64dc632d8ccf474eadb8e5911839b251 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
por: Akane Kawamura, et al.
Publicado: (2017) -
Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
por: Jose A. Viscarra, et al.
Publicado: (2020) -
The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-β.
por: Anouk K Gloudemans, et al.
Publicado: (2013) -
GSK-3 protein and the heart: friend or foe?
por: B. Huisamen, et al.
Publicado: (2017) -
Reader domain specificity and lysine demethylase-4 family function
por: Zhangli Su, et al.
Publicado: (2016)